91¸£Àû

With projections of costs in the billions for COVID-19 treatments alone, and heightened scrutiny on COVID-19-related health insurance coverage, the 91¸£Àû (91¸£Àû) convened in March 2020 to discuss how the industry could best deal with a pandemic. While the ramifications of the COVID-19 event are in their infant stages, it is important to consider the implications such catastrophic risks have on an insurance market. We evaluate state level changes presented by the 91¸£Àû in response to the COVID-19 pandemic and use prior research to offer insight into health insurance in a post-COVID-19 world. This manuscript aims to provide a summary of the 91¸£Àû’s current standing during the pandemic, while presenting insight into policy implications regarding regulation in health insurance markets during catastrophic events.